Showing 1 - 10 of 504
, we focus on patients newly diagnosed with cancer. They display the familiar pattern: even among cancer patients with … reductions. We also find that among patients with the same cancer type and initial prognosis, end-of-life spending is …
Persistent link: https://www.econbiz.de/10012482381
uninsured women with breast cancer, we compared insured and uninsured women treated in a safety net setting. Controlling for … that, despite the safety net system, uninsured women with breast cancer are likely to require more costly treatment and to … have worse outcomes, relative to insured women with breast cancer …
Persistent link: https://www.econbiz.de/10012464772
breast cancer treatments, where lumpectomy with radiation therapy is more expensive than mastectomy but generates similar …
Persistent link: https://www.econbiz.de/10012458440
Increased health care spending has been argued to be largely due to technological change. Cost-effectiveness analysis is the main tool used by private and public third-party payers to prioritize adoption of the new technologies responsible for this growth. However, such analysis by payers...
Persistent link: https://www.econbiz.de/10012463617
In recent years, considerable attention has been devoted to the development of statistical methods for the analysis of uncertainty in cost-effectiveness analysis, with a focus on situations in which the analyst has patient-level data on the costs and health effects of alternative interventions....
Persistent link: https://www.econbiz.de/10012472372
Most medical cost-effectiveness analyses include future costs only for related illnesses but this approach is controversial. This paper demonstrates that cost-effectiveness analysis is consistent with lifetime utility maximization only if it includes all future medical and non-medical...
Persistent link: https://www.econbiz.de/10012472878
We use a unique, nationally representative cross-national dataset to document the reduction in individuals' usage of routine non-emergency medical care in the midst of the economic crisis. A substantially larger fraction of Americans have reduced medical care than have individuals in Great...
Persistent link: https://www.econbiz.de/10012462809
Between 1960 and 1997, life expectancy at birth of Americans increased approximately 10% - from 69.7 to 76.5 years - and it has been estimated that the value of life extension during this period nearly equaled the gains in tangible consumption. We investigate whether an aggregate health...
Persistent link: https://www.econbiz.de/10012469960
We investigate the effect of managed care on the health care system, focusing on the effects managed care could have on the number and types of health care providers and their efficiency. By influencing providers, managed care may change the structure and performance of the entire health care...
Persistent link: https://www.econbiz.de/10012472831
Increasing levels of HMO activity may influence health expenditures in other sectors of the market. Medicare provides FFS coverage to the majority of its beneficiaries and may thus provide a way of examining these so-called spillover effects. This paper examines 1986-1990 Medicare FFS...
Persistent link: https://www.econbiz.de/10012473509